Wire Stories

3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics

BUDAPEST, Hungary--(BUSINESS WIRE)--Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member…

Strike Brings Lightning-Fast Money Transfers from the U.S. to Vietnam

CHICAGO--(BUSINESS WIRE)--Strike, the world’s leading digital payments platform built on Bitcoin’s Lightning Network, today announced…

InMoment Launches CX Industry’s First Innovations Leveraging ChatGPT in the XI Platform to Solve Real-World Business Challenges for Clients

Distill hundreds of individual customer comments into an easy to understand short overview of the…

AM Best Affirms Credit Ratings of China Taiping Insurance (Macau) Company Limited

HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the…

Thailand Data Center Portfolio Report 2023: Current IT Load Capacity 2022 & Future Capacity Additions 2023-2025 – Analysis of 28 Existing Data Centers & 14 Upcoming Data Centers – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thailand: Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's…

New Research Finds Majority of US and UK Consumers Believe Economy Won’t Improve in 2023; Shoppers Reducing Spend in Half of Retail Categories

Study reveals consumers will make purchasing decisions based on emotional connection and price relief through…

Renesas’ New RZ/T2L Industrial MPU Enables Fast and Accurate Real-Time Control with EtherCAT Communication

Software Compatibility with Other Renesas MPUs/MCUs Allows Developers to Seamlessly Implement Scalable Design TOKYO--(BUSINESS WIRE)--#Renesas--Renesas…

OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia

Phase 1 trial of OLX72021 has been approved for initiation in Australia OliX will evaluate…

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in…